Attention to Incentives

October 7, 2015 updated by: University of Pennsylvania
In this experiment, the investigators will test the effectiveness of a two week 20x incentive multiplier on the investigators' corporate partner's users who are (a) not notified about the incentives in advance, and (b) notified about the incentives and their purpose. The investigators will test which group shows the largest boost in walking during the two week intervention and the most lasting behavior change.

Study Overview

Detailed Description

Summary:

In this experiment, the investigators will test the effectiveness of a two week 20x incentive multiplier on AchieveMint users who are (a) not notified about the incentives in advance, and (b) notified about the incentives and their purpose. The investigators will test which group shows the largest boost in walking during the two week intervention and the most lasting behavior change.

Information:

The experimental conditions will vary the type and amount of information about incentives as follows:

  • Condition 1 - Uninformed: Users will receive 20x their usual incentives for two weeks, but will receive no emails informing them about the incentive program. (They may find out about incentives through the Achievemint platform.)
  • Condition 2 - Informed about Incentives and Purpose: Users will receive 20x their usual incentives for two weeks, and they will receive emails informing them about the incentives (one announcement before the incentives begin, and one email every two days reminding them about the overall incentive program). These emails will contain information about the incentives and the purpose of the incentives. Condition 2 will most closely resemble the "constant" condition in the previous experiment. Roughly the same initial announcement email will go out. The reminder emails sent every two days, however, will include more information about the overall program incentives to maximize the number of participants who learn about the incentive program at some point.

Mock-ups of the email announcements and reminders are shown below.

Incentives:

The investigators' incentives will consist of multipliers for points offered via Achievemint. Since the investigators found in the investigators' last experiment that the constant incentives were the most successful, the investigators will offer these incentives to all treated participants: 20x multipliers for 14 days.

Other details:

The other details of the experiment will be the same as the previous experiment:

  • Length of incentives: the investigators will offer incentives for 14 days.
  • Post-intervention observation: the investigators will observe all treatment groups for at least 30 days after the intervention.

Study Type

Interventional

Enrollment (Actual)

2055

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • University of Pennsylvania

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

-

Exclusion Criteria:

  • top 30 percentiles of active walkers
  • To the extent possible, given the investigators' target sample size, the investigators will exclude users who were enrolled in the investigators' previous experiment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Uninformed
Condition 1
Users will receive 20x their usual incentives for two weeks, but will either receive no emails informing them about the incentive program.
Experimental: Informed about Incentives and Purpose
Condition 2
Users will receive 20x their usual incentives for two weeks, and they will receive emails informing them about the incentives (one announcement before the incentives begin, and one email every two days reminding them about the overall incentive program). These emails will contain information about the incentives and the purpose of the incentives. The reminder emails sent every two days, however, will include more information about the overall program incentives to maximize the number of participants who learn about the incentive program at some point.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of steps taken
Time Frame: 30 days
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Katherine L. Milkman, Ph.D., University of Pennsylvania
  • Principal Investigator: Bradford Tuckfield, University of Pennsylvania
  • Principal Investigator: Leslie K. John, Ph.D., HBS
  • Principal Investigator: Francesco Gino, Ph.D., HBS

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2015

Primary Completion (Actual)

May 1, 2015

Study Registration Dates

First Submitted

April 2, 2015

First Submitted That Met QC Criteria

April 7, 2015

First Posted (Estimate)

April 8, 2015

Study Record Updates

Last Update Posted (Estimate)

October 12, 2015

Last Update Submitted That Met QC Criteria

October 7, 2015

Last Verified

July 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 819369

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Informed and Uninformed Incentives

Clinical Trials on Uninformed

Subscribe